Glycogen is the storage form of glucose in the body, primarily found in the liver and skeletal muscles.
It consists of branched chains of glucose monomers linked together.
Metabolism of Glycogen
Glycogen can be converted to glucose when needed for energy.
Glycogenolysis: Process by which glycogen is broken down to glucose-1-phosphate and subsequently to glucose.
Glycolysis: The breakdown of glucose into pyruvate to generate energy.
Enzymatic regulation is critical in these metabolic pathways.
Glycogen Storage Disorders (GSDs)
These disorders arise from issues in the enzymes that regulate glycogen metabolism.
There are over 15 types of GSDs, each associated with mutations in specific enzymes.
Common types include:
Type 1 (Von Gierke's disease): Affects glucose-6-phosphatase enzyme.
Type 2 (Pompe disease): Involves the lysosomal enzyme acid alpha-glucosidase (GAA).
Type 5 (McArdle disease): Results from deficiency of glycogen phosphorylase.
The heterogeneity of GSDs means they can be caused by mutations in different genes.
Clinical Impact of GSDs
Symptoms vary depending on the type but may include muscle weakness, hypoglycemia, and organ enlargement.
The body struggles to either break down or transport glycogen properly.
Genetics of GSDs
Genetic variety among individuals can lead to different severity of symptoms (expressivity) and different presentations (penetrance).
Genetic complementation: Occurs when affected parents with different mutations can have unaffected children due to inheritance of functional alleles from each parent.
Key Terms
Heterogeneity: Referring to genetic disorders that can result from mutations in multiple unrelated genes.
Expressivity: Variation in the severity of the phenotype expressed by individuals with the same genotype.
Penetrance: The proportion of individuals with a particular genotype that actually exhibit the phenotype.
Pleiotropy: A single gene mutation leading to multiple phenotypic effects.